Calumet Specialty Products Partners LP (CLMT) Investment Analysis

1. Executive Summary:

Calumet, Inc. (NASDAQ: CLMT), headquartered in Indianapolis, Indiana, serves as a prominent player in the North American specialty chemicals and renewable energy sectors. The company’s operational framework encompasses twelve facilities strategically positioned across the continent, where it manufactures, formulates, and markets a diversified slate of specialty branded products alongside a rapidly expanding renewable fuels portfolio. Historically structured as a Master Limited Partnership (MLP), Calumet underwent a transformational conversion to a C-Corporation on July 10, 2024. This strategic evolution was designed to dismantle the barriers to institutional investment, as the previous partnership structure excluded many mutual funds and passive indices, which typically represent twenty to thirty percent of the ownership in peer C-Corporations.

The enterprise generates revenue through three primary reporting segments: Specialty Products and Solutions (SPS), Performance Brands (PB), and Montana/Renewables (MR). The SPS segment is the bedrock of the company, focusing on customer-oriented formulation businesses that produce lubricating oils, solvents, and waxes for industrial and consumer-facing markets. Performance Brands focuses on high-margin, branded products such as TruFuel, serving a wide array of retail and industrial customers. The Montana/Renewables segment represents the company’s high-growth frontier, consisting of the Great Falls refinery and the Montana Renewables LLC (MRL) biorefinery, which produces Sustainable Aviation Fuel (SAF), Renewable Diesel (RD), and other low-carbon derivatives.

Revenue is derived from a mix of long-term customer contracts and spot market sales. In the specialty segments, revenue quality is enhanced by deep integration into customer supply chains, where Calumet provides specialized formulations that are critical to the end-user’s manufacturing processes. In the renewable segment, revenue is increasingly underpinned by long-term offtake agreements with major airlines, with approximately 100 million gallons of SAF already fully committed or in final contracting stages as of late 2025. Financial results for the fiscal year 2025, based on preliminary data, indicate a significant narrowing of net losses and a robust Adjusted EBITDA between $285.0 million and $305.0 million. This performance is buoyed by a $220 million reduction in restricted debt, facilitated by operational cost improvements and the strategic $110 million divestiture of the Royal Purple industrial business.

Transformational Growth Pivot

2. Business Drivers & Strategic Overview:

The strategic core of Calumet’s investment thesis lies in its pivot from a traditional petroleum refinery model toward a high-margin, sustainable fuels and specialty chemicals leader. This shift is driven by three primary catalysts: the scaling of the Montana Renewables biorefinery, a relentless focus on "Commercial Excellence" within the specialty segments, and an aggressive deleveraging program intended to re-rate the company’s valuation multiples.

Montana Renewables and the SAF Opportunity

The Montana Renewables (MRL) facility in Great Falls, Montana, is the crown jewel of Calumet’s growth strategy. It currently operates as one of only three commercial-scale SAF producers in North America. The facility’s primary competitive advantage is its geographic "moat," which allows it to source low-carbon feedstocks—such as tallow, distillers corn oil, and canola—directly from the agricultural hubs of the Pacific Northwest and Western Canada. By processing these feedstocks via a sophisticated pre-treatment unit, MRL achieves lower Carbon Intensity (CI) scores, which in turn maximizes the value of environmental credits.

The MaxSAF™ 150 expansion is the segment’s immediate revenue driver. Management has successfully de-risked this project by identifying ways to debottleneck existing assets, reaching a target of 120 million to 150 million gallons of annualized SAF production by the second quarter of 2026. Notably, this "breakthrough" was achieved for a fraction of the original capital expenditure estimate, costing approximately $20 million to $30 million versus the previously projected $150 million to $250 million. The strategic importance of SAF cannot be overstated; the aviation sector remains one of the most difficult industries to decarbonize, and SAF is currently the only viable near-term solution to meet international and domestic emission reduction targets.

Specialty Products and Performance Brands: The Cash Engine

While the renewable segment captures growth-oriented interest, the Specialty Products and Solutions (SPS) segment provides the foundational cash flow. This segment has transitioned from a volume-based approach to a margin-maximization strategy labeled "Commercial Excellence." In 2025, the SPS segment achieved record production and maintained strong margins even amidst commodity price fluctuations, reporting $80.2 million in Adjusted EBITDA for the third quarter alone. The segment benefits from high barriers to entry, as the specialized refining processes required to produce high-purity waxes and solvents are capital-intensive and require deep technical expertise.

The divestiture of the Royal Purple industrial business in March 2025 for $110 million exemplifies management’s commitment to portfolio optimization. By shedding non-core assets, the company has streamlined its Performance Brands segment to focus on high-growth retail products like TruFuel, which saw 7% year-over-year volume growth in early 2025.

Financial Engineering and Deleveraging

A critical business driver is the reduction of interest expense and the extension of debt maturities. The successful closing of a $1.44 billion Department of Energy (DOE) loan in early 2025 was a watershed moment. This loan replaced high-cost third-party debt at Montana Renewables, eliminating approximately $80 million in annual cash debt service. Furthermore, in January 2026, the company issued $405 million in new 9.75% Senior Notes due 2031 to redeem outstanding 11.00% and 8.125% notes, effectively pushing the nearest material debt maturity to 2028.

Strategic Renewable Leadership

3. Financial Performance & Valuation:

The financial landscape for Calumet in 2025 and the beginning of 2026 reflects a company in the midst of a successful turnaround. Preliminary results for fiscal year 2025 indicate a significant improvement in profitability and balance sheet health, although GAAP net income remains pressured by non-cash charges and historical debt burdens.

2025 Historical Performance Summary

For the year ended December 31, 2025, Calumet expects to report a net loss between $69.0 million and $12.0 million. However, the more relevant metric for valuation, Adjusted EBITDA with Tax Attributes, is projected to be between $285.0 million and $305.0 million. This performance marks a dramatic surge compared to prior years, driven by the realization of $61 million in year-over-year operating cost savings and record production in the specialty segment.

In the third quarter of 2025, the company reported a net income of $313.4 million, or $3.61 per share, representing a 411.5% improvement over the prior year period. This surge was primarily attributed to strong specialty product sales and gains in the fuels sub-segment, which benefited from a 1.3 million barrel increase in annual production.

Key Financial Metrics and Liquidity

As of December 31, 2025, Calumet’s liquidity position has been fortified to approximately $447 million, inclusive of restricted cash. The Restricted Subsidiaries Group, which holds the specialty business assets, reduced its debt by more than $220 million during the year.

Valuation and Peer Analysis

Calumet’s current valuation is complex due to its dual nature as both a specialty chemical manufacturer and a renewable fuel producer. On a Price-to-Sales (P/S) basis, the stock trades at approximately 0.6x, which is in line with its fair ratio but sits above the 0.2x average of traditional refining peers like Par Pacific or Delek US. This premium is justified by the higher-margin nature of its specialty business and the substantial growth potential of its SAF assets.

Market capitalization as of February 2026 stands at approximately $2.55 billion, with the share price recently touching a 52-week high of $29.20. Analysts have provided a consensus price target of approximately $21.25 to $23.45, although some bull-case estimates range as high as $33.00, citing free cash flow comparables to Darling Ingredients. The forward-looking EBITDA for the combined company is projected to reach approximately $750 million by 2028, driven by the full ramp-up of Montana Renewables.

Fundamental Re-Rating Underway

4. Risk Assessment & Macroeconomic Considerations:

Despite the positive trajectory, Calumet’s business model is subject to several high-impact risks, ranging from regulatory shifts to commodity price volatility and interest rate sensitivity.

Regulatory and Legislative Risks

The most significant risk to the renewable segment is the transition to the Section 45Z Clean Fuel Production Credit. The passage of the "One Big Beautiful Bill Act" (OBBBA) in mid-2025 introduced substantial changes to the incentive landscape. While the OBBBA extended the 45Z credit through 2029, it reduced the maximum per-gallon credit for SAF from $1.75 to $1.00, placing it on parity with other biofuels. This represents a 43% reduction in the potential tax incentive, which could compress the margins of the Montana Renewables segment if voluntary premiums from airlines do not compensate for the loss.

Furthermore, starting in 2026, the 45Z credit will mandate the use of domestic feedstocks (sourced from the U.S., Canada, or Mexico). While Calumet is currently well-positioned to meet these requirements due to its Pacific Northwest sourcing strategy, any disruption in regional supply chains or a significant increase in the cost of domestic tallow and corn oil could impair project economics.

Macroeconomic Sensitivities

Calumet’s financial health is closely tied to the "WCS-WTI" spread—the price difference between Western Canadian Select and West Texas Intermediate crude oil. The Great Falls refinery benefits from a seasonally weak WCS environment, which lowers its feedstock costs. A narrowing of this spread would reduce the competitive advantage of its Montana operations. Additionally, the company remains exposed to broader commodity price fluctuations; although specialty products are less volatile, the fuels sub-segment is highly cyclical.

Capital Structure and Interest Rate Risk

Although Calumet has successfully refinanced its near-term maturities, it still carries a significant debt load. The company’s Altman Z-Score of 1.24 puts it in the "distress zone," indicating that financial stability remains a primary concern. A persistent high-interest-rate environment would increase the cost of future refinancings, particularly for the senior notes due in 2028 and 2029. Moreover, the company has less than one year of cash runway as of late 2025, making it dependent on continuous operational execution and the successful monetization of tax credits ($90 million was monetized in 2025).

Operational and Execution Risks

The MaxSAF™ 150 project is a central pillar of the investment thesis. Any delay in the Q2 2026 startup or a failure to achieve the 120-150 million gallon production target would delay the expected EBITDA ramp. Additionally, the complex nature of renewable fuel production involves technical challenges that could result in reduced volumes, as seen during the SAF expansion test run in 3Q 2025.

Regulatory and Leverage Vulnerability

5. 5-Year Scenario Analysis:

Developing a realistic five-year outlook for Calumet requires an assessment of its production capacity, the regulatory incentive structure, and the successful execution of its deleveraging plan. The current share price of approximately $29.39 serves as the baseline for this analysis.

Assumptions and Financial Inputs

The fundamental driver for all scenarios is the Montana Renewables expansion. We assume the base production of the specialty segments remains stable at approximately $200 million to $250 million in annual EBITDA, while the renewable segment scales significantly.

• Sales Growth: Driven by the jump from 30 million gallons to 150 million gallons of SAF in 2026, and further expansion to 300 million gallons by 2028.

• EBITDA Margins: Dependent on the 45Z credit (assumed at $1.00/gallon) and voluntary premiums (assumed at $0.10-$0.50/gallon).

• Share Count: Assumed stable at 86.75 million shares following the C-Corp conversion.

• Valuation Multiple: Refineries typically trade at 4x-6x EBITDA, but renewable pure-plays can command 10x-12x. We use a blended range of 6x-9x.

Scenario 1: High Case - The "Renewable Giant"

In this scenario, Calumet hits all MaxSAF targets early, captures massive voluntary premiums from airlines, and successfully deleverages to a 3.0x Net Debt/EBITDA ratio.

• Fundamentals: SAF reaches 300 million gallons by 2028. EBITDA margins per gallon average $1.50 due to superior feedstock CI optimization.

• EBITDA (2030): $850 million ($250M Specialty + $600M Renewable).

• Projected Share Price: $72.00 (9x EV/EBITDA).

Scenario 2: Base Case - "Pragmatic Execution"

Calumet achieves 150 million gallons of SAF by 2026 and 300 million by late 2029. 45Z remains at $1.00/gallon with moderate premiums.

• Fundamentals: Sales growth follows management's roadmap. EBITDA margins average $1.10/gallon. The company pays down $500M in debt using free cash flow.

• EBITDA (2030): $650 million ($225M Specialty + $425M Renewable).

• Projected Share Price: $42.50 (7.5x EV/EBITDA).

Scenario 3: Low Case - "Regulatory and Operational Headwinds"

Execution delays at MaxSAF 150 and the expiration of the 45Z credit after 2029 lead to a valuation "cliff."

• Fundamentals: SAF capacity stalls at 150 million gallons. Margins drop to $0.50/gallon as incentives expire. High leverage prevents refinancing at favorable rates.

• EBITDA (2030): $350 million ($180M Specialty + $170M Renewable).

• Projected Share Price: $11.50 (5x EV/EBITDA).

5-Year Share Price Trajectory Table

Probability Weighted Outcome

• High (25% weight): $18.00 contribution

• Base (55% weight): $23.38 contribution

• Low (20% weight): $2.30 contribution

• Target Price: $43.68

Asymmetric Upside Potential

6. Qualitative Scorecard:

Management Alignment: 8 / 10

Management incentives are robustly structured around shareholder value creation. CEO Todd Borgmann’s base salary was increased to $800,000 as of 12/31/2024, but the bulk of his compensation is tied to long-term incentives. The 2025 LTIP introduced Performance Stock Units (PSUs) equally weighted toward relative Total Shareholder Return (TSR) and net deleveraging milestones. Insider ownership stands at approximately 4.1% to 22%, depending on the inclusion of major institutional affiliates like The Heritage Group. While there has been some selling by independent directors (~$4.7 million over the past year), this is often common following a C-Corp conversion for tax and liquidity reasons.

Revenue Quality: 7 / 10

The company’s revenue is transitioning from merchant fuel volatility to specialized contract-based income. The forward-placement of 100 million gallons of SAF is a significant indicator of high-quality, predictable revenue. The Specialty Products segment benefits from "sticky" customer relationships in the food, pharma, and industrial sectors. However, the continued reliance on environmental credits (RINs, PTCs) introduces a non-market risk element.

Market Position: 8 / 10

Calumet is "winning" in the renewable fuels space, particularly in SAF, where it is a commercial first-mover in North America. Once the MaxSAF expansion reaches full capacity, MRL is expected to produce about half of all North American SAF and 12% of global supply through 2030. In the specialty segment, Calumet holds leading positions in niche formulations, such as pre-blended fuel (TruFuel) and high-purity waxes.

Growth Outlook: 9 / 10

The growth potential is exceptional. Management’s plan to nearly double EBITDA in 2026 and potentially triple it by 2028 is backed by tangible asset debottlenecking and a $1.44 billion federal loan. The aviation industry’s "Grand Challenge" to decarbonize ensures long-term demand for the company’s primary expansion product.

Financial Health: 4 / 10

This remains the company’s weakest point. With a "CCC+" rating from S&P, negative shareholder equity, and an Altman Z-score of 1.24, Calumet is still in a precarious financial position. Interest coverage is low (0.12x - 0.65x), although this is expected to improve as EBITDA ramps and high-cost notes are retired.

Business Viability: 7 / 10

The core specialty business is highly durable, with a history dating back to 1990. The primary "choke point" is the regulatory landscape for biofuels. If state or federal incentives were suddenly removed, the economics of the Montana Renewables expansion would be compromised. However, the underlying industrial demand for specialty chemicals provides a reliable safety net.

Capital Allocation: 7 / 10

Management has been disciplined, divesting non-core industrial brands for $110 million and prioritizing every dollar of cash flow for MRL expansion and debt reduction. The decision to "debottleneck" MaxSAF for $30 million instead of building a $150 million reactor demonstrates excellent capital efficiency.

Analyst Sentiment: 6 / 10

Sentiment is mixed but shifting toward positive. While the consensus rating is currently a "Hold" with a target price below the current trading level, the "Strong Buy" rating from 60% of analysts reflects a belief in the long-term transformation. Recent target price increases from firms like Goldman Sachs suggest growing institutional confidence.

Profitability: 5 / 10

Calumet is just beginning to turn the corner. The massive 411.5% improvement in 3Q 2025 net income is a promising signal, but consistent GAAP profitability has not yet been achieved. Net margin remains slightly negative (-0.92%).

Track Record: 5 / 10

The historical track record as an MLP was marred by high leverage and frequent secondary offerings. However, the current management team under Todd Borgmann has delivered on several key milestones—C-Corp conversion, DOE loan closing, and cost reductions—ahead of or on schedule, rebuilding shareholder trust.

OVERALL BLENDED SCORE: 6.6 / 10

Execution-Critical Transformation

7. Conclusion & Investment Thesis:

Calumet, Inc. is at a critical juncture in its corporate lifecycle, evolving from a leveraged specialty refiner into a dominant force in the North American sustainable aviation fuel market. The investment thesis is built on three pillars: the massive capacity ramp-up at Montana Renewables, the operational stability provided by the Specialty Products segment, and the structural re-rating of the stock following its transition to a C-Corporation structure.

The successful closing of the $1.44 billion DOE loan and the subsequent $220 million reduction in restricted debt in 2025 have significantly de-risked the balance sheet, though the company’s "CCC+" credit rating serves as a reminder of the inherent risks. The primary catalyst for 2026 will be the startup of the MaxSAF™ 150 project in the second quarter, which is expected to catalyze a substantial increase in free cash flow and EBITDA.

Investors must weigh the high growth potential against significant regulatory risks, particularly the compression of SAF tax credits under the OBBBA and the potential for feedstock supply disruptions. However, with a probability-weighted price target of approximately $43.68—suggesting a significant upside from current levels—the fundamental turnaround appears to be gathering momentum. The company’s unique geographic position and first-mover advantage in the aviation decarbonization space provide a durable competitive moat that is difficult for peers to replicate.

Renewable Growth Inflection

8. Technical Analysis, Price Action & Short-Term Outlook:

Calumet (CLMT) is currently displaying strong bullish momentum, recently touching a 52-week high of $29.20 and trading well above its 200-day moving average of $17.42 to $18.66. The Relative Strength Index (RSI) of 75.4 indicates the stock is in overbought territory, suggesting that while the trend is strongly positive, a short-term correction or consolidation period may be imminent. Technical indicators provide a "Strong Buy" signal based on 12 different moving averages, reflecting high optimism ahead of the Q4 and FY 2025 earnings release on February 27, 2026.

Overbought Bullish Momentum